MDS Pharma Services

Parthenon Capital acquires Bracket

Friday, August 16, 2013 10:15 AM

Bracket, a specialty services provider, has been acquired by Parthenon Capital Partners, a growth-oriented private equity firm based in Boston and San Francisco, from Express Scripts Holding Company.

More... »

First MDS consortium to conduct trials and research to improve patient outcomes

Thursday, June 14, 2012 09:23 AM

Taussig Cancer Institute at Cleveland Clinic will participate in an unprecedented, six-institution consortium designed to conduct clinical trials and research to improve outcomes for patients with myelodysplastic syndrome (MDS).

More... »

Crane joins SNBL USA

Monday, November 7, 2011 10:47 AM

More... »

CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »

Potthoff named president, CEO of Theorem Clinical Research

Wednesday, November 2, 2011 01:13 PM

John Potthoff has stepped down as chief operating officer of CRO INC Research to become president and CEO of Theorem Clinical Research, succeeding James Pusey, who now becomes Theorem’s executive chairman to the board of directors.

More... »

Cetero says FDA’s actions ‘difficult to understand’—company notified agency of chemists’ misconduct

Monday, August 1, 2011 08:02 AM

Large, early-phase CRO Cetero Research seemed blindsided by the FDA’s letter to the company last week accusing it of falsifying data and manipulating samples over a five-year period at its Houston bioanalytics lab.

More... »

Harlan names Manuela Leone president, CRS

Wednesday, April 27, 2011 12:01 PM

Global CRO Harlan Laboratories has appointed Dr. Manuela Leone as president of contract research services (CRS) for the company.

More... »

Firecrest Clinical Appoints New CEO

Thursday, May 20, 2010 09:06 AM

Firecrest Clinical, an eClinical solution provider, announces the appointment of Alan Horgan as CEO.

More... »

MDS’ Early-Stage CRO Reborn as Celerion

Monday, March 29, 2010 01:30 PM

Part of MDS’ early-stage contract research organization (CRO), which was sold off in two parts earlier this month, is re-emerging as Celerion, a CRO owned by a group of private investors.

More... »

MDS Completes Sale of Discovery, Preclinical Portion of CRO

Tuesday, March 9, 2010 06:07 AM

MDS completed its sale of the discovery and preclinical business of MDS Pharma Services, the company’s contract research organization (CRO).  Under the terms of the deal, CRO Ricerca Biosciences of Concord, Ohio, acquired facilities in Bothell, Wash.; Lyon, France; and Taipei, Taiwan. Those facilities have 600 employees.

More... »